Need of Generating Level 1 Evidence in the Therapy of Endocrine Glands

SEARCH WITHIN CONTENT

Online First

Anurag Srivastava

Citation Information : Srivastava A. Need of Generating Level 1 Evidence in the Therapy of Endocrine Glands. 2021; 16 (1):1-4.

DOI: 10.5005/jp-journals-10088-11163

License: CC BY-NC 4.0

Published Online: 26-08-2021

PDF Share

Surgical research: the reality and the IDEAL. Lancet 2009;374(9695):1037. DOI: 10.1016/S0140-6736(09)61678-0. PMID: 19782850.
Horton R. Surgical research or comic opera: questions, but few answers. Lancet 1996;347(9007):984–985. DOI: 10.1016/s0140-6736(96)90137-3. PMID: 8606606.
Bunker JP, Barnes BA, Mosteller F. Costs, risks and benefits of surgery. Oxford: Oxford University Press; 1977.
Baum M. Reflections on randomised controlled trials in surgery. Lancet 1999;353(Suppl. 1):SI6-SI8. DOI: 10.1016/s0140-6736(99)90220-9. PMID: 10319923.
Ford I, Norrie J. Pragmatic Trials. N Engl J Med 2016;375(5):454–463. DOI: 10.1056/NEJMra1510059. PMID: 27518663.
Hill AB. Memories of the British streptomycin trial in tuberculosis. The first randomised clinical trial. Control Clinical Trials 1990;11(2):77–79. DOI: 10.1016/0197-2456(90)90001-I.
Hahn S. Understanding noninferiority trials. Korean J Pediatr 2012;55(11):403–407. DOI: 10.3345/kjp.2012.55.11.403.
Ramsey SD, McIntosh M, Sullivan SD. Design issues for conducting cost-effectiveness analyses alongside clinical trials. Annu Rev Public Health 2001;22(1):129–141. DOI: 10.1146/annurev.publhealth.22.1.129.
Noor Haslinda I, Juni MH, Rosliza AM, et al. Designing and conducting cost-effectiveness analysis studies in health care. Int J Public Health Clin Sci 2017;4(5):62–76.

PDF Share